TheraVet completes first regulatory milestones for the US registration (NADA) of VISCO-VET in canine osteoarthritis
June 15, 2020
TheraVet S.A., the specialist of the osteo-articular diseases in small companion animals, announces today passing the first regulatory milestones for its product VISCO-VET in the indication of canine osteoarthritis with the U.S. Food & Drug Administration's (FDA) Center for Veterinary Medicine (CVM). Since its creation in 2019, TheraVet USA has...
PREVIOUS PRESS RELEASES
TheraVet starts its US operations in its Texas-based subsidiary
November 7, 2019
TheraVet S.A., the specialist of the osteo-articular diseases of small companion animals, announced today the incorporation of its Texas-based subsidiary and the launch of its activities in the United States of America. The incorporation of TheraVet USA, earlier this year...